Drug Research
Enesi Pharma inks pact with NIH to evaluate ImplaVax-enabled flu vaccines
Enesi Pharma has entered into an agreement with the US National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to test a novel ImplaVax enabled pandemic flu vaccine.
ImplaVax-enabled vaccination products leverage Enesi's innovative unit solid-dose,...
Drug Research
Silence and Hansoh partner to develop siRNA-based treatments
Silence Therapeutics and Hansoh Pharmaceutical have entered a partnership to develop small-interfering ribonucleic acid (siRNAs) drugs for three undisclosed targets using the former’s mRNAi GOLD platform.
Following the conclusion of the Phase I clinical trial, Hansoh will hold an exclusive...
Clinical Trials
Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration
Antios Therapeutics, Inc. and Assembly Biosciences, Inc. announced that the companies have entered into a clinical collaboration agreement to evaluate a triple combination treatment in patients with chronic hepatitis B virus (HBV) infection. A single cohort in the ongoing...
Clinical Trials
Moleculin obtains UK MHRA authorisation for Phase Ia trial of Covid-19 drug
Moleculin Biotech has obtained the UK Medicines and Healthcare Products Regulatory Agency (MHRA) authorisation to initiate a Phase Ia clinical trial of its drug, WP1122, in the country to treat Covid-19.
An inhibitor of metabolism/glycosylation, WP1122 is a prodrug of...
Drug Research
Stevanato Group Wins Pharma Innovation Award For AI-ready Vision Robot Unit (VRU)
Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has been recognized as a winner of Pharma Manufacturing magazine’s 2021 Pharma Innovation Award for its AI-ready Vision...
News
Aptar CSP Technologies Awarded $19 Million Contract to Expand Production Capacity for its Active Film Technology
Aptar CSP Technologies, part of AptarGroup, Inc., and a leader in active material science solutions that ensure product protection, extend shelf life and improve user experience, was awarded a $19 million contract from the U.S. government. This award will...
News
West Introduces DeltaCube Modeling Platform and NovaGuard SA Pro Safety System for 0.5 mL Standard Glass Syringes at Interphex
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will unveil its DeltaCube™ Modeling Platform as well as the new NovaGuard® SA Pro Safety System for ISO 0.5mL Standard Glass Syringes...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















